Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile


Contract Service Directory


Fresenius Kabi Contract Manufacturing





Company Headquarters

Borkenberg 14
Oberursel, 61440
Germany

Contract Service Directory

    Related Content

    • Breaking News | Collaborations & Alliances | Industry News | Supply Chain
      Vizient and Fresenius Kabi Expand Partnership

      Vizient and Fresenius Kabi Expand Partnership

      Complete Novaplus contract enhancement for six critical care drugs.
      11.26.19

    • Breaking News | Facilities | Industry News
      Lilly to Invest $400M in Manufacturing Facilities

      Lilly to Invest $400M in Manufacturing Facilities

      Company to add approximately 100 jobs in Indianapolis expansion.
      11.22.19

    • Biologics, Proteins, Vaccines
      Regenerative Medicine: Overcoming the supply chain challenges

      Regenerative Medicine: Overcoming the supply chain challenges

      Accomplishing the goal of widespread use of regenerative medicine doesn’t come without its challenges.
      Rich Quelch, Global Head of Marketing, Origin 11.20.19


    • Breaking News | Industry News
      Vineti, WuXi AppTec Ink Personalized Therapy Management Platform Pact

      Vineti, WuXi AppTec Ink Personalized Therapy Management Platform Pact

      To combine Vineti's ordering and traceability platform with WuXi's manufacturing facilities to provide end-to-end solution
      11.05.19


    • APIs
      Better Drug Manufacturing Strategies: Custom APIs

      Better Drug Manufacturing Strategies: Custom APIs

      Today’s biopharma companies are turning to their contractors for long-term collaboration and much higher levels of support.
      Tom Wilson, VP, Global Contract Manufacturing Leader, Pfizer CentreOne 10.15.19


    • APIs | cGMP Manufacture | Clinical Trial Materials | Custom Sourcing News | Industry News
      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Nordic Nanovector, Isotope Technologies Enter Supply Pact

      Extend global supply agreement for n.c.a. Lutetium-177 (EndolucinBeta)
      10.07.19

    • Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development
      Continued and Consistent Investment in Manufacturing Facilities

      Continued and Consistent Investment in Manufacturing Facilities

      As companies move their cell and gene therapies through the development process, supporting larger Phase III trials and commercial launches will be a challenge
      Ryan Carpentier, Executive Director of Business Development, Cryoport 09.23.19



    • Cytotoxics and High Potency Manufacturing
      API to ADC: A Journey Through High Potency

      API to ADC: A Journey Through High Potency

      This class of compounds represents a major advance in oncology research and treatment application.
      Maurits Janssen, Head Commercial Development API, Lonza Pharma & Biotech 09.16.19

    • 22	ASTELLAS

      22 ASTELLAS

      ...
      07.15.19

    • 02	Novartis

      02 Novartis

      ...
      07.15.19


    • Collaborations & Alliances | Drug Development
      Gilead and Nurix to Collaborate on Novel Therapies

      Gilead and Nurix to Collaborate on Novel Therapies

      Consisting of targeted protein degradation drugs for patients with cancer and other challenging diseases
      06.20.19